iPSC-CO-4
HIHCNi008-A
General
Cell Line |
|
| hPSCreg name | HIHCNi008-A |
| Cite as: | HIHCNi008-A (RRID:CVCL_C3RI) |
| Alternative name(s) |
iPSC-CO-4
|
| Cell line type | Human induced pluripotent stem cell (hiPSC) |
| Similar lines |
HIHCNi008-A-3 (iPSC-REEP1_homKO2) HIHCNi008-A-4 (iPSC-REEP1_hetKO2) |
| Last update | 2nd February 2024 |
| User feedback | |
Provider |
|
| Generator | Hertie Institute for Clinical Brain Research - Clinical Neurogenetics (HIHCN) |
| Owner | Hertie Institute for Clinical Brain Research - Clinical Neurogenetics (HIHCN) |
External Databases |
|
| Cellosaurus | CVCL_C3RI |
| Wikidata | Q116049327 |
| BioSamples | SAMEA115164120 |
General Information |
|
| * Is the cell line readily obtainable for third parties? |
No |
| Subclones | |
Donor Information
General Donor Information |
|
| Sex | male |
| Ethnicity | caucasian |
Phenotype and Disease related information (Donor) |
|
| Diseases | No disease was diagnosed.
|
Other Genotyping (Donor) |
|
| Is there genome-wide genotyping or functional data available? |
No
|
Donor Relations |
|
| Other cell lines of this donor | |
External Databases (Donor) |
|
| BioSamples | SAMEA115124423 |
Ethics
| Has informed consent been obtained from the donor of the embryo/tissue from which the pluripotent stem cells have been derived? | Yes |
| Was the consent voluntarily given? | Yes |
| Has the donor been informed that participation will not directly influence their personal treatment? | Yes |
| Can you provide us with a copy of the Donor Information Sheet provided to the donor? | No |
| Provide contact information of the holder of the original Donor Information Sheet: | Prof. Dr. Ludger Schöls |
| Do you (Depositor/Provider) hold the original Donor Consent Form? | No |
| If you do not hold the Donor Consent Form, do you know who does? | Yes |
| Contact information / weblink | Prof. Dr. Ludger Schöls |
| Please indicate whether the data associated with the donated material has been pseudonymised or anonymised. | pseudonymised |
| Does consent explicitly allow the derivation of pluripotent stem cells? | Yes |
| Does consent prevent CELLS DERIVED FROM THE DONATED BIOSAMPLE from being made available to researchers anywhere in the world? | No |
| How may genetic information associated with the cell line be accessed? | No information |
| Will the donor expect to receive financial benefit, beyond reasonable expenses, in return for donating the biosample? | No |
| Has a favourable opinion been obtained from a research ethics committee, or other ethics review panel, in relation to the Research Protocol including the consent provisions? | Yes |
| Name of accrediting authority involved? | Institutional Review Board of the Medical Faculty, University of Tübingen |
| Approval number | 598/2011BO1 |
| For generation of the cell line, who was the supplier of any recombined DNA vectors or commercial kits used? |
hIPSC Derivation
General |
|
| Source cell type |
Synonyms
|
Reprogramming method |
|
| Vector type | Non-integrating |
| Vector | Episomal |
Vector free reprogramming |
|
Other |
|
| Derived under xeno-free conditions |
Unknown |
| Derived under GMP? |
Unknown |
| Available as clinical grade? |
Unknown |
Culture Conditions
| Medium |
Essential 8™
|
Characterisation
Analysis of Undifferentiated Cells
| Marker | Expressed | Immunostaining | RT-PCR | Flow Cytometry | Enzymatic Assay | Expression Profiles |
| Alkaline Phosphatase |
Yes |
|||||
| POU5F1 (OCT-4) |
Yes |
|||||
| TRA 1-81 |
Yes |
Differentiation Potency
Genotyping
Karyotyping (Cell Line) |
|
| Has the cell line karyotype been analysed? |
No
|
Other Genotyping (Cell Line) |
|
Login to share your feedback, experiences or results with the research community.